🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 86366E106
- Market Cap
- Mid Cap
- IPO
- 2/3/2023 · $15.00/share
- ADR Ratio
- 1:3
Business: Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs, The company has built a pipeline including two clinical-stage small molecule compounds designed to overcome the limitations of biologics and peptide therapies.
Company Contact
- CEO
- Raymond Stevens
- CFO
- Jun Yoon
- Headquarters
- 611 Gateway Blvd., Suite 223, South San Francisco, CA 94080
- Phone
- 628-229-9277
- Investor Relations
- ir@structuretx.com